FDA Drug · D-0852-2026

Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01

Class II · Ongoing

Failed Dissolution Specifications

Affected lots / codes — check yours against thisBatch # RISA24002; Exp Date: 04/2027

Recalling firm: Inventia Healthcare Limited, Kalyan, N/A
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 13567 bottles
Distribution: U.S. Nationwide
Recall initiated: September 3, 2026
Classified: September 17, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0852-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →